Alpha Tau Medical (DRTS) Equity Average (2022)
Alpha Tau Medical's (DRTS) quarterly Equity Average came in at $106.5 million in Q4 2022, down 1.21% quarter-over-quarter from $107.8 million in Q3 2022.
Alpha Tau Medical (DRTS) Equity Average (2022) Analysis & Trends
Alpha Tau Medical has disclosed Equity Average across 1 years of filings, most recently posting $106.5 million for Q4 2022.
- Equity Average for Q4 2022 came in at $106.5 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2022 was $106.5 million (changed N/A YoY), and the FY2025 annual result was $69.9 million, down 5.01% from the prior year.
- Equity Average came in at $106.5 million for Q4 2022 at Alpha Tau Medical, down from $107.8 million in the prior quarter.
- In the past five years, Equity Average ranged from a high of $107.8 million in Q3 2022 to a low of $29.6 million in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 3.50 Bn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 783.14 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 3.76 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 1.01 Bn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 21.35 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 19.01 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 516.41 Mn |
| 10 | Alpha Tau Medical | 2,416.70 | -76.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 106.46 Mn |
| Sep 30, 2022 | 107.76 Mn |
| Jun 30, 2022 | 101.13 Mn |
| Mar 31, 2022 | 29.61 Mn |